secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001193125-26-207530
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics ups ATM offering to $7.5M; 71,830 shares sold to date
--------------------------------------------------------------------

- Increased maximum aggregate offering price under ATM facility to $7.5 million.
- 71,830 shares of common stock sold to date under Sales Agreement with H.C. Wainwright & Co.
- ATM offering uses existing S-3 shelf registration (effective Feb 10, 2025); prospectus supplement filed May 5, 2026.
- Legal opinion and consent of Sichenzia Ross Ference Carmel LLP filed as exhibits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526207530/0001193125-26-207530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526207530/fblg-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-207530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer